← Back to Search

Apple Watch Monitoring for Glioblastoma

N/A

Waitlist Available

Led By Siamrut Patanavanich

Research Sponsored by Case Comprehensive Cancer Center

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

at least 18 years of age at the time of study enrolment

Karnofsky Performance Status (KPS) ≥ 70% at time of study enrolment

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 6 months

Awards & highlights

Study Summary

This trial is studying how Apple watch data can predict shifts in feelings, and aid in preventing complications before they occur. #research

Who is the study for?

This trial is for adults over 18 with glioblastoma, either newly-diagnosed or recurrent, who are undergoing treatment or surveillance. Participants need to understand the consent form, have an iPhone to use with the Apple Watch app, and be physically active enough (KPS ≥ 70%). It's not for those under 18, unable to consent due to language barriers, without an iPhone, having wrist tattoos/skin conditions affecting the watch sensor or unable to wear the watch consistently.Check my eligibility

What is being tested?

The study tests if measurements from an Apple Watch—like walking data, heart rate, breathing rate and sleep patterns—can relate to how patients feel during treatment changes. The goal is using this data to predict complications or symptom changes in advance.See study design

What are the potential side effects?

There are no direct medical side effects from participating as it involves monitoring through an Apple Watch. However, participants may experience discomfort wearing the device consistently.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I am 18 years old or older.

Select...

I am mostly able to care for myself and carry out daily activities.

Select...

I have a new or returning glioblastoma and am under treatment or watchful waiting.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 6 months

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~6 months

This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Success rate of 16-hour wear-time

Symptom collection success rate

Trial Design

1Treatment groups

Experimental Treatment

Group I: Wearing the Apple watch and the associated logging of health dataExperimental Treatment1 Intervention

As part of the monitoring needed for this study, participants will be enrolled for at least 6 months, as this will give enough data to understand how the participant's health changes associate with what is measured by the Apple watch. After this 6 month period, participants may choose to end their participation on the study, or continue if they wish.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Apple Watch

2015

N/A

~440

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Case Comprehensive Cancer CenterLead Sponsor

453 Previous Clinical Trials

31,844 Total Patients Enrolled

Siamrut PatanavanichPrincipal InvestigatorCleveland Clinic Foundation, Case Comprehensive Cancer Center

Andrew Dhawan, MD, DPhilPrincipal InvestigatorBrain Tumor Institute, Cleveland Clinic Foundation, Case Comprehensive Cancer Center

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is recruitment still going on for this experiment?

"According to the details available on clinicaltrials.gov, this research is not presently accepting participants. Initially published in April of 2024 and last updated in November of 2023, no new candidates are being sought at present. Despite this, 667 other trials have open recruitment opportunities as we speak."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Glioblastoma Remote Monitoring and Care - Research Protocol

2024. "Glioblastoma Remote Monitoring and Care - Research Protocol". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT06129760.